Discontinuation report NOVAHISTEX DH

Last updated on 2020-08-04 History
Report ID 98371
Drug Identification Number 02049481
Brand name NOVAHISTEX DH
Common or Proper name Novahistex DH
Company Name SANOFI-AVENTIS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE
Strength(s) 20MG 5MG
Dosage form(s) SYRUP
Route of administration ORAL
Packaging size 100ml
ATC code R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-03-31
Actual discontinuation date 2020-04-09
Remaining supply date 2020-03-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments last lot 8131851 expiry 2022-05-29
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-08-04 French Compare
v3 2020-08-04 English Compare
v2 2019-11-11 French Compare
v1 2019-11-11 English Compare